Subscribe to Newsletter

Small Molecules

Business & Regulation Business Practice

Business in Brief

| Stephanie Vine

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?
Business & Regulation Business Practice

Adapting to Change

| Maryam Mahdi

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.
Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.
Discovery & Development Drug Discovery

The Gut Response

| Maryam Mahdi

In what ways can the microbiome interact with oral medicines?
Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Vine

Nominations are now open for The Medicine Maker 2021 Power List.

Manufacture Standards & Regulation

A Blossoming Market

| Maryam Mahdi

How is the Indian pharmaceutical industry adapting to meet new demands?
Manufacture Small Molecules

A Year of Challenge and Opportunity

| Maryam Mahdi

How do we manage the fallout caused by the COVID-19 pandemic?
Manufacture Technology and Equipment

The Trends Behind the Tech

| Maryam Mahdi

Richard Stedman from ACG Engineering outlines the trends driving change in the Indian pharmaceutical equipment industry.
Manufacture Technology and Equipment

Breaking With Tradition

| Mark Muldowney

Is continuous manufacturing worth the investment for pharma companies?
Business & Regulation Small Molecules

Sayonara, Serendipity

| James Strachan

How can small molecule "degraders" help target disease-causing proteins?
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker